These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35438141)

  • 1. Reactivation in major organ involvement following SARS-CoV-2 mRNA vaccination in Behçet's syndrome patient receiving immunosuppressive therapy.
    Yıldırım R; Üsküdar Cansu D; Dinler M; Korkmaz C
    Rheumatology (Oxford); 2022 Jun; 61(SI2):SI197-SI199. PubMed ID: 35438141
    [No Abstract]   [Full Text] [Related]  

  • 2. Behçet's-like adverse event or inaugural Behçet's disease after SARS-CoV-2 mRNA-1273 vaccination?
    Tagini F; Carrel L; Fallet B; Gachoud D; Ribi C; Monti M
    Rheumatology (Oxford); 2022 May; 61(5):e112-e113. PubMed ID: 34617989
    [No Abstract]   [Full Text] [Related]  

  • 3. Behçet's patients' response to COVID-19 vaccination.
    Gokani B; Sacoor S; Leisegang GR; Ogunkolade W; Bibi A; Grigoriadou S; Pade C; Gibbons J; Senusi A; Fortune F
    Clin Immunol; 2023 Oct; 255():109700. PubMed ID: 37482118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of Behçet's disease post-SARS-CoV2-vaccination: two clinical cases in Japan.
    Hashizume H; Ajima S; Ishikawa Y
    J Eur Acad Dermatol Venereol; 2022 Apr; 36(4):e248-e249. PubMed ID: 34897826
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine.
    Ozdede A; Guner S; Ozcifci G; Yurttas B; Toker Dincer Z; Atli Z; Uygunoğlu U; Durmaz E; Uçar D; Uğurlu S; Saip S; Tabak F; Hamuryudan V; Seyahi E
    Rheumatol Int; 2022 Jun; 42(6):973-987. PubMed ID: 35376962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of patients with Behçet's disease during the COVID-19 pandemic.
    Dursun R; Temiz SA; Özer İ; Daye M; Ataseven A
    Dermatol Ther; 2020 Nov; 33(6):e14063. PubMed ID: 32710599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical course of SARS-CoV-2 infection in patients with Behçet's syndrome.
    Mattioli I; Bettiol A; Silvestri E; Urban ML; Palermo A; Fagni F; Malandrino D; Del Bianco A; Prisco D; Emmi G
    Clin Exp Rheumatol; 2021; 39 Suppl 132(5):47-50. PubMed ID: 34128795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy.
    Syversen SW; Jyssum I; Tveter AT; Tran TT; Sexton J; Provan SA; Mjaaland S; Warren DJ; Kvien TK; Grødeland G; Nissen-Meyer LSH; Ricanek P; Chopra A; Andersson AM; Kro GB; Jahnsen J; Munthe LA; Haavardsholm EA; Vaage JT; Lund-Johansen F; Jørgensen KK; Goll GL
    Arthritis Rheumatol; 2022 Aug; 74(8):1321-1332. PubMed ID: 35507355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-SARS-CoV-2 vaccination, safety and disease exacerbation in Behçet's syndrome: Correspondence.
    Sookaromdee P; Wiwanitkit V
    Int J Rheum Dis; 2022 Nov; 25(11):1343. PubMed ID: 35909252
    [No Abstract]   [Full Text] [Related]  

  • 10. Adamantiades-Behçet's disease (Behçet's disease) and COVID-19.
    Zouboulis CC; van Laar JAM; Schirmer M; Emmi G; Fortune F; Gül A; Kirino Y; Lee ES; Sfikakis PP; Shahram F; Wallace GR
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e541-e543. PubMed ID: 33914986
    [No Abstract]   [Full Text] [Related]  

  • 11. Progression of coronary disease in a Behcet's patient in remission.
    Abeyewickreme A; Ramoutar A; Kabir A
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22761229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 in patients with Behçet's disease: Outcomes and rate of Behçet's exacerbations in a retrospective cohort.
    Polat B; Erden A; Güven SC; Armağan B; Karakaş Ö; Özdemir B; Apaydın H; Usul E; Ateş İ; Küçükşahin O; Omma A
    Mod Rheumatol; 2022 Feb; 32(2):455-459. PubMed ID: 34910209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelodysplastic syndrome with monosomy 7 after immunosuppressive therapy in Behçet's disease.
    Bangerter M; Griesshammer M; v Tirpitz C; Krauter J; Heil G; Hafner M; Kern W; Heiss M; Kern P
    Scand J Rheumatol; 1999; 28(2):117-9. PubMed ID: 10229142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic thromboembolic pulmonary hypertension secondary to Behçet's disease: an extremely rare pediatric case.
    Mahdavi M; Asadian S; Rezaeian N; Asl Fallah S; Shahzadi H; Toloueitabar Y
    Cardiol Young; 2022 Feb; 32(2):315-319. PubMed ID: 34294181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy.
    Sugihara K; Wakiya R; Shimada H; Kameda T; Nakashima S; Kato M; Miyagi T; Mizusaki M; Mino R; Nomura Y; Inoo M; Kadowaki N; Dobashi H
    Intern Med; 2022 Jul; 61(13):1953-1958. PubMed ID: 35466168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple peripheral arterial and aortic aneurysms in Behcet's syndrome: a case report.
    Jayachandran NV; Rajasekhar L; Chandrasekhara PK; Kanchinadham S; Narsimulu G
    Clin Rheumatol; 2008 Feb; 27(2):265-7. PubMed ID: 17929077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behçet's disease, myelodysplastic syndrome, trisomy 8, gastroenterological involvement--an association.
    Eder L; Rozenbaum M; Boulman N; Aayubkhanov E; Wolfovitz E; Zisman D; Rosner I
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S91-5. PubMed ID: 16273773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.
    Block JP; Boehmer TK; Forrest CB; Carton TW; Lee GM; Ajani UA; Christakis DA; Cowell LG; Draper C; Ghildayal N; Harris AM; Kappelman MD; Ko JY; Mayer KH; Nagavedu K; Oster ME; Paranjape A; Puro J; Ritchey MD; Shay DK; Thacker D; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(14):517-523. PubMed ID: 35389977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.
    Milo R; Staun-Ram E; Karussis D; Karni A; Hellmann MA; Bar-Haim E; Miller A;
    Front Immunol; 2022; 13():868915. PubMed ID: 35432335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab therapy in parenchymal neuro-Behçet's disease: A single-center experience.
    Yalcin Kehribar D; Gunaydin S; Ozgen M
    Int J Rheum Dis; 2021 Oct; 24(10):1302-1307. PubMed ID: 34427044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.